A postdoctoral fellowship position is available in the laboratory of Dr. Howard A. Rockman at Duke University. The focus of the laboratory is to understand the molecular mechanism and physiological consequence of biased G protein-coupled receptor (GPCR) signaling under normal and pathological cardiac conditions. Overall goal of the laboratory is to identify and characterize new GPCR ligands that have therapeutic potential for cardiovascular disease. Projects involve cellular signaling, pharmacological characterization of compounds and in vivo cardiac physiology. This is an excellent opportunity to participate in an exciting research program, work collaboratively with top GPCR researchers in the field and gain broad expertise in invitro and invivo model systems related to cardiovascular disease.
https://medicine.duke.edu/research/duke-cardiovascular-research/about-us
Qualifications and Experience:
• Motivated and have a strong background in biochemistry and/or cell biology.
• Knowledge in signal transduction and GPCR pharmacology is highly desirable.
• Experience with cell-based assays, protein expression, purification and biochemical characterization is preferred.
Duke University is an Affirmative Action/Equal Opportunity Employer committed to providing employment opportunity without regard to an individual's age, color, disability, gender, gender expression, gender identity, genetic information, national origin, race, religion, sex, sexual orientation, or veteran status.
Duke aspires to create a community built on collaboration, innovation, creativity, and belonging. Our collective success depends on the robust exchange of ideas-an exchange that is best when the rich diversity of our perspectives, backgrounds, and experiences flourishes. To achieve this exchange, it is essential that all members of the community feel secure and welcome, that the contributions of all individuals are respected, and that all voices are heard. All members of our community have a responsibility to uphold these values. |
(posted 2021/05/25, listed until 2021/11/30)